Evidence map›Paper›PMID 34485822›Full record

ArticleJCSM clinical reports2021

The effects of neoadjuvant chemotherapy and interval debulking surgery on body composition in patients with ovarian cancer.

John Vitarello, Marcus D Goncalves, Qin C Zhou, Alexia Iasonos, Darragh F Halpenny, Andrew Plodkowski, Emily Schwitzer, Jennifer J Mueller, Oliver Zivanovic, Lee W Jones and 2 more

Open access · goldAbstract read
In one paragraph

Article in JCSM clinical reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. The comparison of functional status and health-related parameters in ovarian cancer survivors with healthy controls.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

John VitarelloDepartment of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Marcus D GoncalvesDivision of Endocrinology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Qin C ZhouDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Alexia IasonosDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Darragh F HalpennyDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Andrew PlodkowskiDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Emily SchwitzerCardiology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Jennifer J MuellerGynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Oliver ZivanovicGynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Lee W JonesCardiology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Karen A CadooDepartment of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Jason A KonnerDepartment of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Memorial Sloan Kettering Cancer Center · USBeth Israel Deaconess Medical Center · USWeill Cornell Medicine · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Summer research experiences for medical students supervised by faculty mentorsR25CA020449 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Charlotte Eielson Ariyan · 1985 to 2026
$6.2M
The Role of Hypoketonemia in the Cancer Anorexia-Cachexia SyndromeK08CA230318 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI GONCALVES, MARCUS DASILVA · 2018 to 2021
$599k
NCI NIH HHS K08 CA230318NCI NIH HHS P30 CA008748NCI NIH HHS R25 CA020449
6 · The paper itself

Abstract

backgroundThe aim of this study was to quantify changes in body composition during ovarian cancer treatment and relate these changes to rates of complete gross resection (CGR).

methodsOne hundred two patients with stage III or IV ovarian cancer who underwent neoadjuvant chemotherapy (NACT) followed by interval debulking surgery were a part of a prospectively collected database that included computed tomography scans at three time points-diagnosis, following NACT, and following debulking surgery. Skeletal muscle, visceral adipose, and subcutaneous adipose tissue volumes were obtained from a 30-mm volumetric slab beginning at the third lumbar vertebrae.

resultsFollowing NACT, skeletal muscle volume was significantly reduced (352.5 to 335.0 cm

conclusionSkeletal muscle volume was significantly reduced in patients undergoing NACT for ovarian cancer. Non-overweight patients were more likely to achieve CGR if they had lower skeletal muscle volume. Use of volumetric-based measurement for ascertaining body composition should be explored further.

Identifiers

PMID34485822
PMCPMC8415724
OpenAlexW3108554672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.